Metraipolis › archive › dc_05479a4795bb

Pharmacological Privilege: How Glucagon-Like Peptide-1 (GLP-1) Medications are Widening Health Inequalities — Europe PMC PMID:41426804

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41426804
DOI
10.7759/cureus.97124
License (as archived)
solo-consultazione
Archived
2026-11-08T12:02:00.442Z
SHA-256 of the archived text
ca732f485c048ec38d8384256b2dd472ba840402d520c38acfb6f33f737b6db7
Stable URL of this page
https://metraipolis.com/documento/dc_05479a4795bb

How to cite

Pharmacological Privilege: How Glucagon-Like Peptide-1 (GLP-1) Medications are Widening Health Inequalities — Europe PMC PMID:41426804 — Europe PMC (en), https://europepmc.org/article/MED/41426804 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_05479a4795bb (Metraipolis archive dc_05479a4795bb, sha256 ca732f485c048ec38d8384256b2dd472ba840402d520c38acfb6f33f737b6db7)
BibTeX
@misc{dc05479a4795bb,
  title = {Pharmacological Privilege: How Glucagon-Like Peptide-1 (GLP-1) Medications are Widening Health Inequalities — Europe PMC PMID:41426804},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41426804},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_05479a4795bb; sha256 ca732f485c048ec38d8384256b2dd472ba840402d520c38acfb6f33f737b6db7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41426804. Agents can read the archived copy with the MCP tool read_document.